LeeD, KwonSA, KimMA, et al.Effectiveness of atomoxetine augmentation in reducing nonsuicidal self-injury among adolescents with attention problems: A preliminary study. J Child Adolesc Psychopharmacol, 2025; 35(10):554–562; doi: 10.1177/10445463251369688
2.
McNeilGD, MartinezRG, PiacentiniJC, et al.Characteristics and predictors of patient and parent satisfaction in the treatment of youth anxiety disorders. J Child Adolesc Psychopharmacol, 2025; 35(10):563–572; doi: 10.1089/cap.2025.0010
3.
McVoyM, ChumachenkoS, GerstenM, et al.Assessing the predictive utility of quantitative electroencephalography coherence in adolescent major depressive disorder: A machine learning approach. J Child Adolesc Psychopharmacol, 2025; 35(10):544–553; doi: 10.1177/10445463251358742
4.
Pranjić M, Peisch V, Vukšić N, et al, Precision medicine in pediatric attention-deficit/hyperactivity disorder: A systematic review of behavioral, neurobiological and genetic diagnostic Biomarkers. J Dev behav Pediatr 2025;46(5):e481–e498; doi: 10.1097/DBP.0000000000001403
5.
RadoevaPD, MilevVT, HuntJI, et al.Systematic review: White matter microstructural organization in adolescents with depression. JAACAP Open, 2023; 1(4):233–245; doi: 10.1016/j.jaacop.2023.08.006
6.
Recarey-RamaS, Conde-Pumpido ZubizarretaS, BrenllaC, et al.Exploring the sensory profile and pharmacogenetic biomarkers in child and youth ADHD patients undergoing methylphenidate (MPH) treatment: a systematic review conducted in European studies. Psychiatr Res, 2025; 190:512–521. doi: 10.1016/j.jpsychires.2025.09.002
7.
Strawn JR, Larson J. Anxiety disorders and their treatment in youth: A new era. Child Adolesc Psychiatr Clin N Am 2023;32(3):xi–xii; doi: 10.1016/j.chc.2023.03.001
8.
ValadezEA, TottenhamN, KoromM, et al.A randomized controlled trial of a parenting intervention during infancy Alters Amygdala-Prefrontal circuitry in middle childhood. J Am Acad Child Adolesc Psychiatry, 2024; 63(1):29–38; doi: 10.1016/j.jaac.2023.06.015
